Colombia seeks position in clinical trials

AI executive summary
The story at a glance, best enjoyed with a coffee ☕
The global clinical trials market is projected to double its value by 2034, reaching $130 billion. Colombia has potential to compete in this sector, with solid hospital infrastructure, scientific base, and 165 certified research centers. However, it faces regulatory challenges, as INVIMA approval of trials takes at least 5 months, compared to 60-90 days in Argentina, resulting in fewer clinical trials in the country compared to other regional nations.
🔔 Sign in to follow this story and get its updates.
In this story you will find
AI analysis
Why it matters
Developing clinical trials generates health benefits by providing immediate access to innovative medications, creates high-quality jobs, modernizes hospital infrastructure, and attracts foreign direct investment.
▸▾ Rate, add sources or report this story
Sign in to rate this story and add sources.
Community annexes
Coverage of this same story by other outlets, contributed by readers and checked automatically.
Ask about this coverage
Get an AI answer grounded in reports from different outlets, with links to the sources.